LIITNER
Live / Allowed — Approved for publication (as of 30 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Oct 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 50184593
- Mark type
- Word mark
- Filed
- 27 Oct 2026
- Attorney of record
- M. Daniel Spillman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer's disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson's disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use
Owner
- Eli Lilly and Company, INDIANAPOLIS, IN, US
Prosecution history
- 30 Oct 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2026 — ASSIGNED TO EXAMINER
- 27 Oct 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Oct 2026 — APPLICATION FILING RECEIPT MAILED
- 27 Oct 2026 — NEW APPLICATION ENTERED